Cell therapy (Stem-cell derived) · developed by Mesoblast
Provacel is a cell therapy made of ex vivo cultured adult mesenchymal stem cells. It is studied in myocardial infarction and heart failure.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00114452 | Phase 1 | Myocardial Infarction | Completed | MESO |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Myocardial Infarction
Updated Oct 18, 2026. Something wrong or missing? Report it on the MESO page.
See MESO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
MESO catalysts and pipeline →